CCL5 and familial pancreatic carcinoma: aCD40 treatment significantly increased tumoral expression of CCL5, potentially contributing to the recruitment of Granzyme B + CD4 + T cells from TDLNs to the tumor bed, as previously reported in pancreatic cancer models42.